von Redaktion LCGC | Okt. 15, 2012
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer Peifer M, Fernández-Cuesta L, Sos ML, George J, Seidel D, Kasper LH, Plenker D, Leenders F, Sun R, Zander T, Menon R, Koker M, Dahmen I, Müller C, Di Cerbo V, Schildhaus HU,...
von Redaktion LCGC | Okt. 15, 2012
A framework for identification of actionable cancer genome dependencies in small cell lung cancer Sos ML, Dietlein F, Peifer M, Schöttle J, Balke-Want H, Müller C, Koker M, Richters A, Heynck S, Malchers F, Heuckmann JM, Seidel D, Eyers PA, Ullrich RT, Antonchick AP,...
von Redaktion LCGC | Sep. 15, 2012
Monitoring reversible and irreversible EGFR inhibition with erlotinib and afatinib in a patient with EGFR-mutated non-small cell lung cancer (NSCLC) using sequential [18F]fluorothymidine (FLT-)PET Scheffler M, Kobe C, Zander T, Nogova L, Kahraman D, Thomas RK,...
von Redaktion LCGC | Sep. 15, 2012
Indications and limitations of fresh frozen sections in the pulmonary apparatus Pütz K, M. Engels, C. Vollbrecht, L.C. Heukamp, A.C. Adam, R. Büttner Journal: Der Pathologe, Vol 33, No 5, September 2012, doi: 10.1007/s00292-012-1603-yVeröffentlichung: September...
von Redaktion LCGC | Sep. 15, 2012
Comprehensive genomic characterization of squamous cell lung cancers Cancer Genome Atlas Research Network, Hammerman PS, Hayes DN, Wilkerson MD, Schultz N, Bose R, Chu A, Collisson EA, Cope L, Creighton CJ, Getz G, Herman JG, Johnson BE, Kucherlapati R, Ladanyi M,...
